These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20425765)

  • 1. [HIV-1 eradication with the "shock and kill" strategy].
    Schiedel M
    Pharm Unserer Zeit; 2010 May; 39(3):171-3. PubMed ID: 20425765
    [No Abstract]   [Full Text] [Related]  

  • 2. HIV-1 and HAART: a time to cure, a time to kill.
    Saag MS; Kilby JM
    Nat Med; 1999 Jun; 5(6):609-11. PubMed ID: 10371490
    [No Abstract]   [Full Text] [Related]  

  • 3. Understanding HIV latency to undo it.
    Cohen J
    Science; 2011 May; 332(6031):786. PubMed ID: 21566174
    [No Abstract]   [Full Text] [Related]  

  • 4. HDAC inhibitors in HIV.
    Wightman F; Ellenberg P; Churchill M; Lewin SR
    Immunol Cell Biol; 2012 Jan; 90(1):47-54. PubMed ID: 22083528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-2 taken to HAART.
    Gilden D
    GMHC Treat Issues; 1999 Feb; 13(2):4-6. PubMed ID: 11366116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [HIV may be cured].
    Kjær AS; Østergaard HB
    Ugeskr Laeger; 2015 Apr; 177(17):. PubMed ID: 25922162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of antiretroviral therapy on plasma HIV RNA.
    Saag MS
    J Biol Regul Homeost Agents; 1995; 9(3):105-6. PubMed ID: 8782017
    [No Abstract]   [Full Text] [Related]  

  • 8. HIV-1 dynamics in vivo.
    Ho DD
    J Biol Regul Homeost Agents; 1995; 9(3):76-7. PubMed ID: 8782010
    [No Abstract]   [Full Text] [Related]  

  • 9. [Viral dynamics in the course of HIV-1 infection: pathogenetic features and new therapeutic prospects].
    Marcello A; Giacca M
    Pathologica; 2000 Aug; 92(4):291-3. PubMed ID: 11029891
    [No Abstract]   [Full Text] [Related]  

  • 10. Polyamides reveal a role for repression in latency within resting T cells of HIV-infected donors.
    Ylisastigui L; Coull JJ; Rucker VC; Melander C; Bosch RJ; Brodie SJ; Corey L; Sodora DL; Dervan PB; Margolis DM
    J Infect Dis; 2004 Oct; 190(8):1429-37. PubMed ID: 15378435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Scientists investigate routing latent HIV from its reservoirs to achieve a cure.
    Friedrich MJ
    JAMA; 2012 Jul; 308(4):325-7. PubMed ID: 22820767
    [No Abstract]   [Full Text] [Related]  

  • 12. Recurrent HIV-1 integration at the BACH2 locus in resting CD4+ T cell populations during effective highly active antiretroviral therapy.
    Ikeda T; Shibata J; Yoshimura K; Koito A; Matsushita S
    J Infect Dis; 2007 Mar; 195(5):716-25. PubMed ID: 17262715
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV biological phenotype: prognosis marker for transmission, disease progression and therapy.
    Fenyö EM
    J Biol Regul Homeost Agents; 1995; 9(3):88-90. PubMed ID: 8782013
    [No Abstract]   [Full Text] [Related]  

  • 14. Manipulation of the host protein acetylation network by human immunodeficiency virus type 1.
    Jeng MY; Ali I; Ott M
    Crit Rev Biochem Mol Biol; 2015; 50(4):314-25. PubMed ID: 26329395
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of interleukin-2 on the pool of latently infected, resting CD4+ T cells in HIV-1-infected patients receiving highly active anti-retroviral therapy.
    Chun TW; Engel D; Mizell SB; Hallahan CW; Fischette M; Park S; Davey RT; Dybul M; Kovacs JA; Metcalf JA; Mican JM; Berrey MM; Corey L; Lane HC; Fauci AS
    Nat Med; 1999 Jun; 5(6):651-5. PubMed ID: 10371503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.
    Ho DD; Neumann AU; Perelson AS; Chen W; Leonard JM; Markowitz M
    Nature; 1995 Jan; 373(6510):123-6. PubMed ID: 7816094
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uridine excess does not interfere with the antiretroviral efficacy of nucleoside analogue reverse transcriptase inhibitors.
    Koch EC; Schneider J; Weis R; Penning B; Walker UA
    Antivir Ther; 2003 Oct; 8(5):485-7. PubMed ID: 14640397
    [No Abstract]   [Full Text] [Related]  

  • 18. Amino functionalized novel cholic acid derivatives induce HIV-1 replication and syncytia formation in T cells.
    Salunke DB; Ravi DS; Pore VS; Mitra D; Hazra BG
    J Med Chem; 2006 Apr; 49(8):2652-5. PubMed ID: 16610808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. R5 variants of human immunodeficiency virus type 1 preferentially infect CD62L- CD4+ T cells and are potentially resistant to nucleoside reverse transcriptase inhibitors.
    Gondois-Rey F; Biancotto A; Fernandez MA; Bettendroffer L; Blazkova J; Trejbalova K; Pion M; Hirsch I
    J Virol; 2006 Jan; 80(2):854-65. PubMed ID: 16378987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. New approaches in HIV eradication research.
    Frater J
    Curr Opin Infect Dis; 2011 Dec; 24(6):593-8. PubMed ID: 22001946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.